Company intelligence / Profile preview

Betalin Therapeutics

Ramat Gan, Tel Aviv District, Israelbetalintherapeutics.com ↗

Ownership: Private
Employees: ~10
Development stage: Preclinical

Overview

Betalin Therapeutics has developed a proprietary engineered micro-pancreas platform that combines a three-dimensional scaffold with human pancreatic islets and mesenchymal stem cells. In preclinical animal models, the implant demonstrated prolonged viability of transplanted cells and sustained insulin production. The company has completed preclinical studies and received positive feedback from the FDA on its pre-investigational new drug application. Clinical trial preparations are underway at leading centers worldwide.

Therapeutic areas: Endocrinology
Modalities: Cell therapytissue engineering (engineered micro-pancreas using human pancreatic islets and mesenchymal stem cells)
Industry: Biotech

Drug pipeline

1 asset

Engineered micro-pancreas

Preclinical

Partnerships

Ongoing collaboration with Hebrew University of Jerusalem for R&D/licensing of core technologyClinical trial collaborations at major diabetes centers in Germany, China, US; potential expansion to UK.

Beyond the preview

Go deeper on Betalin Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Betalin Therapeutics.

Explore the full profile